Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 4/20 | 0.43 |
| ▸ | GSK3B | P49841 | 5/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.41 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.41 |
| ▸ | SMYD2 | Q9NRG4 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.35 |
| ▸ | BRD4 | O60885 | 2/20 | 0.34 |
| ▸ | NAMPT | P43490 | 1/20 | 0.34 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.34 |
| ▸ | PDE2A | O00408 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13120090 | 0.90 | CDK2 (0.55) | CDK2GSK3BHDAC1HDAC3 | |
| SCHEMBL14418654 | 0.90 | HDAC1 (0.40) | CDK2GSK3BHDAC1HDAC3KCNH2 | |
| SCHEMBL13120016 | 0.88 | CDK2 (0.55) | CDK2GSK3BHDAC1HDAC3KCNH2 | |
| SCHEMBL13289235 | 0.88 | CDK2 (0.45) | CDK2GSK3BHDAC1HDAC3BRD4 | |
| SCHEMBL13288868 | 0.88 | CDK2 (0.52) | CDK2GSK3BHDAC1HDAC3BRD4 | |
| SCHEMBL13289148 | 0.88 | CDK2 (0.52) | CDK2GSK3BPDE2AALDH1A1 | |
| SCHEMBL13288952 | 0.87 | CDK2 (0.44) | CDK2GSK3BHDAC1HDAC3BRD4 | |
| SCHEMBL13288756 | 0.86 | GSK3B (0.40) | CDK2GSK3BBRD4PDE2A | |
| SCHEMBL13289231 | 0.86 | DRD2 (0.46) | CDK2GSK3BHDAC1HDAC3HDAC6 | |
| SCHEMBL13289182 | 0.86 | CDK2 (0.46) | CDK2GSK3BHDAC1SMYD2KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2194058-A1 | Pyrazolopyrimidines suitable for the treatment of cancer diseases | SCHERING CORPORATION (US) | 2010-06-09 | — | — | EP | disclosed |